Features Articles - cell & molecular biology, disease/medicine and funding

The Last Vaccine Frontier

By Brad Spellberg | June 1, 2011

Successful vaccines have been created to protect against pathogenic bacteria and viruses. Why aren’t there any for combating fungal infections?

3 Comments

Recognizing the Human Potential

By Gene M. Shearer and Adriano Boasso | June 1, 2011

It may be time to reconsider an AIDS vaccine which is more human than viral, triggering the immune system in a way that no other vaccine does.

12 Comments

Shooting Down Addiction

By Thomas Kosten | June 1, 2011

A new breed of vaccines aims to wean users off cocaine.

0 Comments

Power Failure

By Megan Scudellari | May 1, 2011

Does mitochondrial dysfunction lie at the heart of common, complex diseases like cancer and autism?

3 Comments

Wrestling with Recurrent Infections

By Gayatri Vedantam and Glenn S. Tillotson | May 1, 2011

Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.

6 Comments

Best Places to Work Industry, 2011

By Hannah Waters | May 1, 2011

By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.

3 Comments

The Movement of Goods Around the Cell

By Patricia Bassereau and Bruno Goud | April 1, 2011

A biologist and a physicist collaborate on a decade-long exploration of the physical parameters of membrane traffic in eukaryotic cells.

0 Comments

Taking Aim at Melanoma

By Keith T. Flaherty | April 1, 2011

Understanding oncogenesis at the molecular level offers the prospect of tailoring treatments much more precisely for patients with advanced cases of this deadliest of skin cancers.

0 Comments

An Aspirin for your Cancer?

By Giorgio Trinchieri | April 1, 2011

Can tumors—which can originate from, and often resemble, chronically inflamed tissue—be curtailed using familiar anti-inflammatory agents, without their side effects?

0 Comments

Epigenetic Changes in Cancer

By Manel Esteller | March 1, 2011

The study of how covalent marks on DNA and histones are involved in the origin and spread of cancer cells is also leading to new therapeutic strategies.

0 Comments